E. Bel (Amsterdam, The Netherlands), P. Paggiaro (Pisa, Italy)
Bronchial mucosal dendritic cells and VEGF expression in COPD patients
A. Zanini, S. Della Patrona, F. Gumiero, M. Majori, D. Olivieri, A. Spanevello, A. Chetta (Varese, Tradate, Parma, Italy)
|   |
Correlation between airway smooth muscle (ASM) and eosinophilic inflammation in severe non-controlled asthmatics
R.M. Carvalho-Pinto, A. Cukier, T. Mauad, M. Dolhnikoff, M.G. Gregório, R.C. Pires Neto, A.M. Teles, K.F. Rabe, R. Stelmach (Sao Paulo, Brazil; Grosshansdorf, Germany)
| |
The EvA study: Characteristics of the study population
L. Ziegler-Heitbrock, D. Burggraf, M. Heiss-Neumann, M. Wjst (Gauting, Neuherberg, Germany)
| |
Characterisation of patients with difficult-to-treat and treatment-resistant severe asthma
F. Novelli, F.L. Dente, M.L. Bartoli, S. Cianchetti, A. Di Franco, L. Melosini, E. Bacci, P. Paggiaro (Italy)
| |
Endogenous hydrogen sulfide (H2S) in serum and sputum as novel biomarker of asthma
J. Saito, Q. Zhang, C. Hui, A. Menzies-Gow, P. Bhavsar, K.F. Chung (London, United Kingdom)
| |
Induced sputum substance P in children with difficult-to-treat bronchial asthma and gastroesophageal reflux: Effect of esomeprazole therapy
A.S. Bediwy, M.G. Elkholy, M. Al-Biltagi, H.G. Amer, E. Farid (Tanta, Shebeen Elkoom, Banha, Egypt)
| |
Clara cell secretory protein (CC16) and surfactant protein D (SPD) in sputum supernatant in severe refractory asthma (SRA)
P. Emmanouil, S. Loukides, K. Kostikas, A. Papaporfyriou, G. Hillas, G. Papatheodorou, S. Papiris, M. Alchanatis, P. Bakakos (Athens, Greece)
| |
Increased levels of angiopoietin 1 & 2 in sputum supernatant in smoking asthma
E. Tseliou, P. Bakakos, K. Kostikas, V. Petta, D. Simoes, G. Hillas, N. Koulouris, S. Papiris, S. Loukides (Athens, Greece)
| |
Short-term and long-term reproducibility of non-invasive clinical and inflammatory parameters in asthma
M. Jung, S. Korn, M. Hübner, C. Taube, R. Buhl (Mainz, Germany; Leiden, Netherlands)
| |
Increased levels of osteopontin in sputum supernatant in patients with COPD
A. Papaporfyriou, S. Loukides, K. Kostikas, G. Hillas, D. Simoes, E. Konstantelou, S. Papiris, N. Koulouris, P. Bakakos, S. Loukides (Athens, Greece)
| |
Reference equation and upper limits of fraction of exhaled nitric oxide (FENO) in a Chinese population
F. Ko, T.F. Leung, G. Wong, J. Chu, I. Sy, D. Hui (Shatin, Hong Kong)
| |
An alternative sampling support for collection of particles in exhaled air
E. Mirgorodskaya, P. Larsson, A. Bredberg, A.C. Almstrand, A.C. Olin (Gothenburg, Sweden)
| |
Endogenous particles in exhaled air – Variability of particle number in healthy individuals
A.C. Almstrand, P. Larsson, A. Bredberg, E. Mirgorodskaya, A.C. Olin (Gothenburg, Sweden)
| |
Microsatellite alterations at 3p and 19q in EBC/DNA of smokers: Are they reversible after smoking cessation?
G.E. Carpagnano, D. Lacedonia, R. Sabato, P. Bonfitto, A. Koutelou, M.P. Foschino Barbaro (Foggia, Italy)
| |
Exhaled MMP-9 in lung cancer
G.E. Carpagnano, D. Lacedonia, E. Costantino, A.R. Depalo, C. Ruggeri, G.P. Palladino, M.P. Foschino Barbaro (Foggia, Italy)
| |
Influence of oral steroid use in difficult-to-control asthma patients on metabolomic profile of oxidative stress in exhaled breath condensate (EXAIR project)
V. Sedlák, P. Cáp, P. Kacer, M. Malý, S. Vlcková, D. Pelclová (Hradec Králové, Prague, Czech Republic)
| |
Ethnic difference and diagnostic value of exhaled nitric oxide levels for predicting asthma in children
G. Wong, T.F. Leung, E. Yung (Shatin, Hong Kong)
| |
Classification ability of two electronic noses in asthma and COPD
R. Capuano, N. Mores, A. Trové, F. Macagno, L. Fuso, C. Mondino, G. Santini, A. D‘Amico, M. Santonico, G. Pennazza, S. Valente, P. Montuschi (Rome, Italy)
| |